Bionano Genomics to Report Third Quarter 2022 Financial Results and Host a Conference Call and Webcast on November 3, 2022
October 27 2022 - 3:01PM
Bionano Genomics, Inc. (BNGO) today announced that it will
host a conference call and live webcast on Thursday, November
3, 2022 at 4:30 p.m. Eastern Time to report
financial results for the third quarter 2022 and to highlight
recent corporate progress.
Conference Call & Webcast Details |
Date: |
Thursday, November 3, 2022 |
Time: |
4:30 p.m. Eastern Time |
Live Call: |
Toll
Free: 1-877-502-9276Toll/International: 1-720-543-0302 |
Live Webcast: |
https://edge.media-server.com/mmc/p/cz29oo8z |
A replay of the conference call and webcast will be archived on
Bionano’s investor relations website at
https://ir.bionanogenomics.com/ for at least 30 days.
About Bionano Genomics
Bionano Genomics is a provider of genome analysis solutions
that can enable researchers and clinicians to reveal answers to
challenging questions in biology and medicine. The Company’s
mission is to transform the way the world sees the genome through
OGM solutions, diagnostic services and software. The Company offers
OGM solutions for applications across basic, translational and
clinical research. Through its Lineagen,
Inc. d/b/a Bionano Laboratories business, the
Company also provides diagnostic testing for patients with clinical
presentations consistent with autism spectrum disorder and other
neurodevelopmental disabilities. Through its BioDiscovery business,
the Company also offers an industry-leading, platform-agnostic
software solution, which integrates next-generation sequencing and
microarray data designed to provide analysis, visualization,
interpretation and reporting of copy number variants,
single-nucleotide variants and absence of heterozygosity across the
genome in one consolidated view.
For more information,
visit www.bionanogenomics.com, www.bionanolaboratories.com or www.biodiscovery.com
CONTACTS
Company Contact:Erik Holmlin, CEOBionano Genomics, Inc.+1 (858)
888-7610eholmlin@bionanogenomics.com
Investor Relations:Amy ConradJuniper Point+1 (858)
366-3243amy@juniper-point.com
Bionano Genomics (NASDAQ:BNGO)
Historical Stock Chart
From Apr 2024 to May 2024
Bionano Genomics (NASDAQ:BNGO)
Historical Stock Chart
From May 2023 to May 2024